Find a Trial

A Phase 2, Open-Label, Multi-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum- Based Chemo as Second-line Treatment for Common EGFR-Mutated Locally Advanced or Metastatic…

Condition: Non-small Cell Lung Cancer

TO Study: LUN24031

Clinic: Elliston Place Plaza, Dickson, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: 61186372NSC2012

NCT07144280

A Study to Learn About the Study Medicine Called PF-08046054/?SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Condition: Non-small Cell Lung Cancer

TO Study: LUN25068

Clinic: Cleveland, Chattanooga Downtown, Dalton, Elliston Place Plaza, Lebanon, Chattanooga Medical Park II, Chattanooga Memorial, Mt. Juliet, Murfreesboro, Ringgold, Shelbyville, Smyrna, St. Thomas West

Protocol: C5851005

NCT07361497

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Condition: Non-small Cell Lung Cancer

TO Study: LUN25075

Clinic: Chattanooga Downtown, Chattanooga East, Clarksville, Cleveland, Columbia, Cookeville, Dalton, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Chattanooga Medical Park II, Chattanooga Memorial, Midtown Women's Health Center, Mt. Juliet, Murfreesboro, Skyline, Southern Hills, St. Thomas West, Ringgold, Shelbyville, Smyrna

Protocol: CA266-0001

A Phase 2, Open-Label, Multi-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination with Platinum- Based Chemo as Second-line Treatment for Common EGFR-Mutated Locally Advanced or Metastatic…

Condition: Non-small Cell Lung Cancer

TO Study: LUN24031

Clinic: Elliston Place Plaza, Dickson, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: 61186372NSC2012

NCT07421700

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Condition: Urothelial Cancer

TO Study: GU25036

Clinic: Cookeville, Chattanooga Downtown, Chattanooga East, Dickson, Elliston Place Plaza, Franklin, Proton Center, Gallatin, Hendersonville, Lebanon, Chattanooga Medical Park II, Chattanooga Memorial, Mt. Juliet, Murfreesboro, Ringgold, Shelbyville, Skyline, Smyrna, So Hills, St. Thomas West

Protocol: C6461006

NCT07227415

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Condition: Renal Cell Carcinoma

TO Study: GU25037

Clinic: Cookeville, Chattanooga Downtown, Chattanooga East, Dickson, Elliston Place Plaza, Franklin, Proton Center, Gallatin, Hendersonville, Lebanon, Chattanooga Medical Park II, Chattanooga Memorial, Mt. Juliet, Murfreesboro, Ringgold, Shelbyville, Skyline, Smyrna, So Hills, St. Thomas West

Protocol: C6461008

NCT07436728

A Study of TAK-505 in Adults With Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25034

Clinic: Elliston Place Plaza

Protocol: TAK-505-1501

NCT05254743

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

TO Study: CLL 53

Clinic: Cleveland, Chattanooga Downtown, Chattanooga Memorial, Chattanooga Medical Park II

Protocol: LOXO-BTK-20030

NCT04989803

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

Condition: Diffuse Large B-Cell Lymphoma

TO Study: LYM25031

Clinic: Elliston Place Plaza

Protocol: KT-US-499-0150

NCT07222566

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Condition: Non-small Cell Lung Cancer

TO Study: LUN25074

Clinic: Chattanooga Downtown, Chattanooga Memorial, Elliston Place Plaza, Franklin, Gallatin, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville

Protocol: C6461001

NCT07288177

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

Condition: Non-small Cell Lung Cancer

TO Study: LUN25085

Clinic: Chattanooga Downtown, Elliston Place Plaza, Chattanooga Memorial, Shelbyville

Protocol: GCT1184-05

NCT07403721

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25031

Clinic: Elliston Place Plaza

Protocol: 20250004

NCT06589596

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25049

Clinic: Elliston Place Plaza

Protocol: BGB-58067-101

NCT07085767

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Condition: Breast Cancer

TO Study: BRE25032

Clinic: Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Midtown Women's Health Center, Mt. Juliet, Murfreesboro, Elliston Place Plaza, St. Thomas West, Skyline, Southern Hills, Ringgold, Shelbyville, Smyrna, Chattanooga Downtown, Chattanooga Memorial, Chattanooga East, Chattanooga Medical Park II, Cleveland, Dalton

Protocol: OP-1250-302

NCT06375044

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

Condition: Multiple Myeloma

TO Study: MM25027

Clinic: Elliston Place Plaza

Protocol: SIM0500-101

NCT06152575

A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY

Condition: Multiple Myeloma

TO Study: MM24004

Clinic: Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Southern Hills, St. Thomas West, Ringgold, Shelbyville, Smyrna, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial, Cleveland, Dalton, Dickson

Protocol: C1071032

NCT06095089

A Phase 1 Study of JNJ-87189401 (PSMA-CD28 Bispecific Antibody) Combined with JNJ-78278343 (KLK2-CD3 Bispecific Antibody) for Advanced Prostate Cancer

Condition: Prostate Cancer

TO Study: GU25032

Clinic: Elliston Place Plaza

Protocol: 87189401PCR1001

NCT07397338

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25044

Clinic: Elliston Place Plaza

Protocol: RMC-APEX-103

NCT07107230

A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25051

Clinic: Elliston Place Plaza

Protocol: 95437446LUC1001

NCT07431281

Phase III, Multi-centre, Ransomised Controlled Study of Sonesitatug vedotin in Combination with Fluoropyrimidine with or without Rilvegostomig in First-line Claudin 18.2-positive HER2-negative Advanced/Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Condition: Esophageal Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction (GEJ) Cancer

TO Study: GI25024

Clinic: Cleveland, Chattanooga Medical Park II, Cookeville, Chattanooga Memorial, Chattanooga Downtown, Mt. Juliet, Chattanooga East, Murfreesboro, Dalton, Ringgold, Dickson, Shelbyville, Franklin, Skyline, Gallatin, Smyrna, Hendersonville, Southern Hills, Lebanon, St. Thomas West

Protocol: D9803C00001

NCT07291076

ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or in Combination with Ipilimumab in Participants with First-Line Advanced or Unresectable Hepatocelluar Carcinoma (HCC)

Condition: Hepatocelluar Carcinoma

TO Study: GI25032

Clinic: Cookeville, Dickson, Elliston Place Plaza, Franklin, Lebanon, Hendersonville, Nashville Breast, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Smyrna, Southern Hills, Skyline

Protocol: CA266-0006

NCT07259317

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Condition: Pancreatic Ductal Adenocarcinoma

TO Study: GI25035

Clinic: Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial, Cookeville, Franklin, Gallatin, Mt. Juliet, Murfreesboro, Shelbyville, Elliston Place Plaza

Protocol: CORT125134-558

NCT06973187

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

TO Study: CLL25011

Clinic: Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Chattanooga East, Dalton, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold

Protocol: BGB-16673-304

NCT07007312

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Condition: Acute Myeloid Leukemia

TO Study: AML24004

Clinic: Elliston Place Plaza

Protocol: KO-MEN-017

NCT07060807

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Condition: Breast Cancer

TO Study: BRE24025

Clinic: Cleveland, Chattanooga Downtown, Dalton, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Chattanooga Medical Park II, Chattanooga Memorial, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills

Protocol: MK-1022-016

NCT06121843

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Condition: Multiple Myeloma

TO Study: MM23012

Clinic: Elliston Place Plaza

Protocol: CA088-1005

NCT06356571

A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (SubQSA)

Condition: Multiple Myeloma

TO Study: MM24003

Clinic: Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Southern Hills, St. Thomas West, Ringgold, Shelbyville, Smyrna, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial, Cleveland, Dalton, Dickson

Protocol: LPS18183

NCT07221474

A Study of V940/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013) (INTerpath-13)

Condition: Non-small Cell Lung Cancer

TO Study: LUN25070

Clinic: Dickson, Skyline, Hendersonville, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: V940-013

NCT06767514

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 (HARMONi-7)

Condition: Non-small Cell Lung Cancer

TO Study: LUN25082

Clinic: Chattanooga Downtown, Chattanooga East, Cleveland, Dalton, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Chattanooga Medical Park II, Chattanooga Memorial, Mt. Juliet, Murfreesboro, Ringgold, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West

Protocol: SMT112-3007

NCT07218380

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract (FORAGER-2)

Condition: Urothelial Cancer

TO Study: GU25026

Clinic: Cleveland, Cookeville, Chattanooga Downtown, Dalton, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Chattanooga Medical Park II, Chattanooga Memorial, Mt. Juliet, Murfreesboro, Ringgold, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West

Protocol: J4G-MC-LZVD

NCT06784193

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25041

Clinic: Elliston Place Plaza

Protocol: OP-3136-101

NCT07228832

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer (HARMONi-GI3)

Condition: Colorectal Cancer

TO Study: GI24021

Clinic: Cookeville, Dickson, Elliston Place Plaza, Franklin, Gallatin, Lebanon, Hendersonville, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold

Protocol: SMT112-3005

NCT07076121

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

Condition: Pancreatic Ductal Adenocarcinoma

TO Study: GI25022

Clinic: Cookeville, Dickson, Elliston Place Plaza, Franklin, Gallatin, Lebanon, Hendersonville, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold

Protocol: CA240-0030

NCT05536141

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors (ARC-20)

Condition: Renal Cell Carcinoma

TO Study: GU25021

Clinic: Cookeville, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial, Chattanooga East

Protocol: AB521

NCT07361562

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25037

Clinic: Elliston Place Plaza

Protocol: CGT4255-25-101

NCT06456463

A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy (TRILLIUM)

Condition: Acute Myeloid Leukemia

TO Study: AML23001

Clinic: Elliston Place Plaza

Protocol: STEML-401-0423

NCT05579366

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/PRO1184-001) (RAINFOL-01)

Condition: Endometrial Cancer, Ovarian Cancer

TO Study: MULTI24014

Clinic: Elliston Place Plaza

Protocol: GCT1184-01

NCT05850234

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

Condition: Multiple Myeloma

TO Study: MM24010

Clinic: Elliston Place Plaza

Protocol: D8310C00001

NCT07288359

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Condition: Breast Cancer

TO Study: EPS25030

Clinic: Elliston Place Plaza

Protocol: CGVV858A12101

NCT05862012

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

Condition: Multiple Myeloma

TO Study: MM24020

Clinic: Elliston Place Plaza

Protocol: ISB 2001-101

NCT06623422

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/?INTerpath-009)

Condition: Non-small Cell Lung Cancer

TO Study: LUN24039

Clinic: Dickson, Skyline, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold, Dalton

Protocol: V940-009

NCT06745908

ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer

Condition: Non-small Cell Lung Cancer

TO Study: LUN24057

Clinic: Lebanon, Cookeville, Hendersonville, Gallatin, Franklin, Chattanooga Medical Park II, Chattanooga Memorial, Mt. Juliet, Murfreesboro, Ringgold, Shelbyville, Skyline, Smyrna, Cleveland, Chattanooga Downtown, Southern Hills, St. Thomas West

Protocol: ResQ201A-NSCLC

NCT07100080

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Condition: Non-small Cell Lung Cancer

TO Study: LUN25064

Clinic: Dickson, Skyline, Hendersonville, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold, Dalton

Protocol: CA244-0010

NCT07353957

Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

Condition: Non-small Cell Lung Cancer

TO Study: LUN25066

Clinic: Dickson, Skyline, Hendersonville, Southern Hills, St. Thomas West, Franklin, Mt. Juliet, Elliston Place Plaza, Lebanon, Shelbyville, Murfreesboro, Gallatin, Smyrna, Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold, Dalton

Protocol: MCLA-158-CL04

NCT06784752

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET (NETTER-3)

Condition: GEP-NET

TO Study: GI24019

Clinic: St. Thomas West, Elliston Place Plaza

Protocol: CAAA601A62301

NCT06501625

Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation

Condition: Cholangiocarcinoma

TO Study: GI25041

Clinic: Murfreesboro

Protocol: S095031-210

NCT07005154

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Condition: Prostate Cancer

TO Study: GU24012

Clinic: Chattanooga Downtown, Chattanooga Memorial , Chattanooga Medical Park II

Protocol: 5541-CL-0201

NCT07224425

A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25024

Clinic: Elliston Place Plaza

Protocol: 1527-0001

NCT06016738

OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-01)

Condition: Breast Cancer

TO Study: BRE25027

Clinic: Dickson, Franklin, Gallatin, Midtown Women's Health Center, Mt. Juliet, Murfreesboro, Elliston Place Plaza, St. Thomas West, Skyline, Southern Hills, Ringgold, Shelbyville, Smyrna, Chattanooga Downtown, Chattanooga Memorial, Chattanooga East, Chattanooga Medical Park II, Cleveland, Dalton, Cookeville

Protocol: OP-1250-301

NCT05614739

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3 (FORAGER-1)

Condition: Urothelial Cancer

TO Study: MULTI24018

Clinic: Elliston Place Plaza

Protocol: LOXO-FG3-22001

NCT07123454

A Phase I/?II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (Lumi-NHL)

Condition: Follicular Lymphoma, Large B-Cell Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma

TO Study: LYM24027

Clinic: Elliston Place Plaza

Protocol: D9890C00001

NCT05872295

IKS014 in Advanced Solid Tumors That Express HER2

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25029

Clinic: Elliston Place Plaza

Protocol: IKS014-01

NCT03424005

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer (Morpheus-panBC)

Condition: Breast Cancer

TO Study: BRE24018

Clinic: Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Midtown Women's Health Center, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: CO40115

NCT07109219

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia (ALLight)

Condition: Acute lymphoblastic leukemia

TO Study: ALL24001

Clinic: Elliston Place Plaza

Protocol: D9891C00001 

NCT06907043

A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25026

Clinic: Elliston Place Plaza

Protocol: EIK1004-001

NCT06982521

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer (ReDiscover-2)

Condition: Breast Cancer

TO Study: BRE25026

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Midtown Women's Health Center, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Southern Hills, Mt. Juliet

Protocol: RLY-2608-102

NCT06806033

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/?Refractory Diffuse Large B-Cell Lymphoma

Condition: Large B-Cell Lymphoma

TO Study: LYM24024

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold

Protocol: GO45434

NCT05061550

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer (NeoCOAST-2)

Condition: Non-small Cell Lung Cancer

TO Study: LUN 494

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Skyline, Smyrna, Southern Hills, St. Thomas West, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold

Protocol: D9077C00001

NCT07164443

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) (KLK2-comPAS)

Condition: Prostate Cancer

TO Study: GU24014

Clinic: Cookeville, Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold

Protocol: 78278343PCR3001  

NCT06874335

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS25022

Clinic: Elliston Place Plaza

Protocol: BHV1530-101

NCT06943872

A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

TO Study: CLL24007

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, Southern Hills, St. Thomas West, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold

Protocol: BGB-11417-303

NCT06112314

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

Condition: Melanoma

TO Study: SKN24005

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, Shelbyville, Skyline, Smyrna, St. Thomas West, Southern Hills

Protocol: PRISM-MEL-301

NCT07121946

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Condition: Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma

TO Study: LYM24023

Clinic: Elliston Place Plaza

Protocol: LTZ-301-001

NCT06324357

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS24016

Clinic: Elliston Place Plaza

Protocol: 1479-0012

NCT06890598

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer (SUNRAY-02)

Condition: Non-small Cell Lung Cancer

TO Study: LUN24050

Clinic: Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold

Protocol: J3M-MC-JZQH

NCT06931626

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

Condition: Small Cell Lung Cancer

TO Study: LUN25053

Clinic: Elliston Place Plaza

Protocol: PARPA-293-004

NCT06423911

Study of Olverembatinib (HQP1351) in Patients With CP-CML (POLARIS-2)

Condition: Chronic Myeloid Leukemia

TO Study: CML24002

Clinic: Dickson, Elliston Place Plaza, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: HQP1351CG301

NCT06667141

Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS24015

Clinic: Elliston Place Plaza

Protocol: ACR-2316-101

NCT06926920

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Condition: Breast Cancer

TO Study: BRE24019

Clinic: Elliston Place Plaza, Murfreesboro

Protocol: GS-US-576-7321

NCT06380751

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer (EvoPAR-BR01)

Condition: Breast Cancer

TO Study: BRE23007

Clinic: Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: D9722C00001

NCT06393374

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR

Condition: Breast Cancer

TO Study: BRE24016

Clinic: Elliston Place Plaza, Lebanon, Smyrna, Southern Hills, Murfreesboro, Mt. Juliet, St. Thomas West, Shelbyville, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: MK-2870-012

NCT05714839

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments (DREAMM-20)

Condition: Multiple Myeloma

TO Study: MM24013

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: 218670

NCT06136559

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

TO Study: CLL23001

Clinic: Dickson, Franklin, Gallatin, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Mt. Juliet, Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: MK-1026-011

NCT06077760

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) (INTerpath-002)

Condition: Non-small Cell Lung Cancer

TO Study: LUN24037

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet

Protocol: V940-002

NCT06252649

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

Condition: Colorectal Cancer

TO Study: GI24010

Clinic: Lebanon, Murfreesboro, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: 20210081

NCT06297226

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)

Condition: Multiple Myeloma

TO Study: MM24014

Clinic: Elliston Place Plaza

Protocol: CA088-1000

NCT06742996

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/?Refractory Mantle Cell Lymphoma

Condition: Mantle Cell Lymphoma

TO Study: LYM24022

Clinic: St. Thomas West, Elliston Place Plaza, Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: BGB-11417-302

NCT06692738

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Condition: Non-small Cell Lung Cancer

TO Study: LUN24026

Clinic: Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville​, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: D702BC00001

NCT06246916

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma

Condition: Melanoma

TO Study: SKN23001

Clinic: Murfreesboro, St. Thomas West, Mt. Juliet, Chattanooga Downtown, Chattanooga Medical Park II

Protocol: R3767-ONC-22122

NCT06119581

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer (SUNRAY-01)

Condition: Non-small Cell Lung Cancer

TO Study: LUN24032

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: J3M-MC-JZQB

NCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence (ELEGANT)

Condition: Breast Cancer

TO Study: BRE24013

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Mt. Juliet, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Southern Hills, Smyrna, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: STML-ELA-0422

NCT04468061

Saci-IO TNBC: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in PD-L1-negative Metastatic Triple Negative Breast Cancer (TNBC)

Condition: Breast Cancer

TO Study: BRE 360

Clinic: Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: 20-166

NCT06517875

Phase 2 Open-label Study to Evaluate Momelotinib in Combination with Luspatercept in Participants with Transfusion Dependent Primary or Secondary Myelofibrosis

Condition: Myelofibrosis

TO Study: MPN24004

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: 220752

NCT05651932

A Phase 1 Study of KTX-1001, an Oral, First-In-Class, Selective, and Potent MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma

Condition: Multiple Myeloma

TO Study: MM 159

Clinic: Elliston Place Plaza

Protocol: K36 MMSET-001

NCT05722418

Phase 1, Multicenter, Open-Label Study of CB-011, a CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (CAMMOUFLAGE Trial)

Condition: Multiple Myeloma

TO Study: MM 161

Clinic: Elliston Place Plaza

Protocol: CB-011

NCT06153251

A Phase 1, Open-Label, Dose-Finding Study of BMS-986453, Dual Targeting BCMAxGPRC5D Chimeric Antigen Receptor T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma

Condition: Multiple Myeloma

TO Study: MM23002

Clinic: Elliston Place Plaza

Protocol: CA119-0002

NCT06171685

MMRC HORIZON ONE: A PHASE II RANDOMIZED ADAPTIVE PLATFORM TRIAL EVALUATING NOVEL THERAPIES IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Condition: Multiple Myeloma

TO Study: MM24011

Clinic: Elliston Place Plaza, Murfreesboro, Smyrna, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: MMRC-099

NCT06479135

A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Condition: Myelofibrosis

TO Study: MPN24003

Clinic: Cleveland, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial, Dalton, Ringgold, Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Elliston Place Plaza

Protocol: KRT-232-115

NCT04830137

A Phase 1, Dose Escalation, Safety and Tolerability Study of NX-2127, a Bruton’s Tyrosine Kinase (BTK) Degrader, in Adults with Relapsed/Refractory B-cell Malignancies.

Condition: Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Primary Central Nervous System Lymphoma, Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia

TO Study: LYM 184

Clinic: Elliston Place Plaza

Protocol: NX-2127

NCT05605899

An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel versus Standard of Care Treatment as First-Line Therapy in Subjects with High-Risk Large B-Cell Lymphoma (ZUMA-23)

Condition: Large B-Cell Lymphoma

TO Study: LYM 206

Clinic: Elliston Place Plaza

Protocol: KT-US-484-0136

NCT05006716

A Phase 1/2, Open-Label, Dose-Escalation and -Expansion Study of the Bruton Tyrosine Kinase-Targeted Protein-Degrader BGB-16673 in Patients With B-Cell Malignancies

Condition: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia

TO Study: LYM23005

Clinic: Elliston Place Plaza

Protocol: BGB-16673-101

NCT06496178

A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared with Investigator’s Choice Monotherapy Treatment in Previously Treated Patients with Incurable, Metastatic/recurrent Head and Neck Squamous Cell Carcinoma

Condition: Head and Neck Squamous Cell Carcinoma

TO Study: HN23003

Clinic: Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: MCLA-158-CL02

NCT06525220

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR – HN1)

Condition: Head and Neck Squamous Cell Carcinoma

TO Study: HN24004

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Southern Hills, Mt. Juliet, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: MCLA-158-CL03

NCT06417814

A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants with EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer whose Disease has Progressed on…

Condition: Non-small Cell Lung Cancer

TO Study: LUN24015

Clinic: Elliston Place Plaza, Dickson, Franklin, Gallatin, Hendersonville, Lebanon, Murfreesboro, St. Thomas West, Shelbyville, Skyline, Smyrna, Southern Hills, Mt. Juliet

Protocol: D516KC00001

NCT06472245

A randomized, open-label, phase 3 trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic Non-Small Cell Lung Cancer (NSCLC) and secondary resistance to Immune Checkpoint Inhibitor (ICI)- ARTEMIA…

Condition: Non-small Cell Lung Cancer

TO Study: LUN24016

Clinic: Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville​, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: OSE2101

NCT06627647

A Phase III, Randomized, Double-Blind, Multicenter, Global Study of Rilvegostomig in Combination with Chemotherapy for First-line Treatment of Patients with Metastatic Non-squamous Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung03)

Condition: Non-small Cell Lung Cancer

TO Study: LUN24029

Clinic: Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: D702FC00001

NCT04862663

A Phase Ib/III Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer…

Condition: Breast Cancer

TO Study: BRE24011

Clinic: Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville

Protocol: D361DC00001

NCT06150664

A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-8371 in Patients with Advanced Malignancies

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS24002

Clinic: Elliston Place Plaza

Protocol: CTX-8371-001

NCT06425926

Phase 1/2, Open-label, Multi-center Study of the Safety, Tolerability, and Efficacy of GIM-531 as a Single Agent and in Combination with Anti-PD-1 in Advanced Solid Tumors

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS24005

Clinic: Elliston Place Plaza

Protocol: GIM531-CT01

NCT06028074

First-in-Human, Open-Label, Phase 1/2 Dose-Escalation with Enrichment and Dose-Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of GIM-122 as a Single Agent in Adult Subjects with Advanced Solid Malignancies

Condition: Relapsed or Refractory Solid Tumors

TO Study: EPS24006

Clinic: Elliston Place Plaza

Protocol: GIM122-CT01

NCT06750094

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/?NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy (OrigAMI-3)

Condition: Colorectal Cancer

TO Study: GI24012

Clinic: Elliston Place Plaza, Murfreesboro, Smyrna, Chattanooga Downtown, Chattanooga Medical Park II, Chattanooga Memorial

Protocol: 61186372COR3002

NCT06103864

A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive…

Condition: Breast Cancer

TO Study: BRE23006

Clinic: Elliston Place Plaza, Lebanon, Skyline, Smyrna, Dickson, Southern Hills, Franklin, Murfreesboro, Mt. Juliet, Gallatin, St. Thomas West, Hendersonville, Shelbyville, Cleveland, Chattanooga Downtown, Dalton, Chattanooga Medical Park II, Chattanooga Memorial, Ringgold

Protocol: D7630C00001